deltatrials
Completed PHASE3 INTERVENTIONAL 2-arm NCT03377699

Research Study Comparing Insulin Degludec to Insulin Detemir, Together With Insulin Aspart, in Pregnant Women With Type 1 Diabetes (EXPECT)

A Trial Comparing the Effect and Safety of Insulin Degludec Versus Insulin Detemir, Both in Combination With Insulin Aspart, in the Treatment of Pregnant Women With Type 1 Diabetes

Sponsor: Novo Nordisk A/S

Updated 40 times since 2018 Last updated: Jan 19, 2023 Started: Nov 22, 2017 Primary completion: Dec 17, 2020 Completion: Dec 17, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03377699, this PHASE3 trial focuses on Diabetes and Diabetes Mellitus, Type 1 and remains completed. Sponsored by Novo Nordisk A/S, it has been updated 40 times since 2017, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2018 – ~Feb 2018 · 31 days · monthly snapshot~Feb 2018 – ~Mar 2018 · 28 days · monthly snapshot~Mar 2018 – ~Apr 2018 · 31 days · monthly snapshot~Apr 2018 – ~May 2018 · 30 days · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshot~Jul 2018 – ~Aug 2018 · 31 days · monthly snapshot~Aug 2018 – ~Sep 2018 · 31 days · monthly snapshot~Sep 2018 – ~Oct 2018 · 30 days · monthly snapshot~Oct 2018 – ~Nov 2018 · 31 days · monthly snapshot~Nov 2018 – ~Dec 2018 · 30 days · monthly snapshot~Dec 2018 – ~Feb 2019 · 2 months · monthly snapshot~Feb 2019 – ~Mar 2019 · 28 days · monthly snapshot~Mar 2019 – ~Apr 2019 · 31 days · monthly snapshot~Apr 2019 – ~May 2019 · 30 days · monthly snapshot~May 2019 – ~Jun 2019 · 31 days · monthly snapshot~Jun 2019 – ~Sep 2019 · 3 months · monthly snapshot~Sep 2019 – ~Oct 2019 · 30 days · monthly snapshot~Oct 2019 – ~Nov 2019 · 31 days · monthly snapshot~Nov 2019 – ~Dec 2019 · 30 days · monthly snapshot~Dec 2019 – ~Jan 2020 · 31 days · monthly snapshot~Jan 2020 – ~Feb 2020 · 31 days · monthly snapshot~Feb 2020 – ~Apr 2020 · 2 months · monthly snapshot~Apr 2020 – ~May 2020 · 30 days · monthly snapshot~May 2020 – ~Jun 2020 · 31 days · monthly snapshot~Jun 2020 – ~Jul 2020 · 30 days · monthly snapshot~Jul 2020 – ~Aug 2020 · 31 days · monthly snapshot~Aug 2020 – ~Sep 2020 · 31 days · monthly snapshot~Sep 2020 – ~Oct 2020 · 30 days · monthly snapshot~Oct 2020 – ~Nov 2020 · 31 days · monthly snapshot~Nov 2020 – ~Dec 2020 · 30 days · monthly snapshot~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshot~Jan 2021 – ~Nov 2021 · 10 months · monthly snapshot~Nov 2021 – ~Dec 2021 · 30 days · monthly snapshot~Dec 2021 – ~May 2022 · 5 months · monthly snapshot~May 2022 – ~Feb 2023 · 9 months · monthly snapshot~Feb 2023 – ~Jul 2024 · 17 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 11 months · monthly snapshot

Change History

40 versions recorded
  1. Sep 2025 — Present [monthly]

    Completed PHASE3

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  4. Feb 2023 — Jul 2024 [monthly]

    Completed PHASE3

  5. May 2022 — Feb 2023 [monthly]

    Completed PHASE3

Show 35 earlier versions
  1. Dec 2021 — May 2022 [monthly]

    Completed PHASE3

  2. Nov 2021 — Dec 2021 [monthly]

    Completed PHASE3

  3. Jan 2021 — Nov 2021 [monthly]

    Completed PHASE3

    Status: Active Not RecruitingCompleted

  4. Dec 2020 — Jan 2021 [monthly]

    Active Not Recruiting PHASE3

  5. Nov 2020 — Dec 2020 [monthly]

    Active Not Recruiting PHASE3

  6. Oct 2020 — Nov 2020 [monthly]

    Active Not Recruiting PHASE3

  7. Sep 2020 — Oct 2020 [monthly]

    Active Not Recruiting PHASE3

  8. Aug 2020 — Sep 2020 [monthly]

    Active Not Recruiting PHASE3

  9. Jul 2020 — Aug 2020 [monthly]

    Active Not Recruiting PHASE3

  10. Jun 2020 — Jul 2020 [monthly]

    Active Not Recruiting PHASE3

  11. May 2020 — Jun 2020 [monthly]

    Active Not Recruiting PHASE3

  12. Apr 2020 — May 2020 [monthly]

    Active Not Recruiting PHASE3

  13. Feb 2020 — Apr 2020 [monthly]

    Active Not Recruiting PHASE3

    Status: RecruitingActive Not Recruiting

  14. Jan 2020 — Feb 2020 [monthly]

    Recruiting PHASE3

  15. Dec 2019 — Jan 2020 [monthly]

    Recruiting PHASE3

  16. Nov 2019 — Dec 2019 [monthly]

    Recruiting PHASE3

  17. Oct 2019 — Nov 2019 [monthly]

    Recruiting PHASE3

  18. Sep 2019 — Oct 2019 [monthly]

    Recruiting PHASE3

  19. Jun 2019 — Sep 2019 [monthly]

    Recruiting PHASE3

  20. May 2019 — Jun 2019 [monthly]

    Recruiting PHASE3

  21. Apr 2019 — May 2019 [monthly]

    Recruiting PHASE3

  22. Mar 2019 — Apr 2019 [monthly]

    Recruiting PHASE3

  23. Feb 2019 — Mar 2019 [monthly]

    Recruiting PHASE3

  24. Dec 2018 — Feb 2019 [monthly]

    Recruiting PHASE3

  25. Nov 2018 — Dec 2018 [monthly]

    Recruiting PHASE3

  26. Oct 2018 — Nov 2018 [monthly]

    Recruiting PHASE3

  27. Sep 2018 — Oct 2018 [monthly]

    Recruiting PHASE3

  28. Aug 2018 — Sep 2018 [monthly]

    Recruiting PHASE3

  29. Jul 2018 — Aug 2018 [monthly]

    Recruiting PHASE3

  30. Jun 2018 — Jul 2018 [monthly]

    Recruiting PHASE3

  31. May 2018 — Jun 2018 [monthly]

    Recruiting PHASE3

  32. Apr 2018 — May 2018 [monthly]

    Recruiting PHASE3

  33. Mar 2018 — Apr 2018 [monthly]

    Recruiting PHASE3

  34. Feb 2018 — Mar 2018 [monthly]

    Recruiting PHASE3

  35. Jan 2018 — Feb 2018 [monthly]

    Recruiting PHASE3

    First recorded

Nov 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Novo Nordisk A/S
Data source: Novo Nordisk A/S

For direct contact, visit the study record on ClinicalTrials.gov .